Bausch & Lomb Corp 8-K/A

What Happened Bausch + Lomb Corporation filed Amendment No. 1 to a Form 8-K to report committee assignments for two recently appointed board members. On December 17, 2025 the company had reported the appointments of Eduardo C. Alfonso, MD and Steven H. Collis to its board effective January 1, 2026; this December 22, 2025 amendment states Dr. Alfonso will join the Science and Technology Committee and Mr. Collis will join the Talent and Compensation Committee, each effective January 1, 2026. The filing was signed by A. Robert D. Bailey, Executive Vice President and Chief Legal Officer.

Key Details

• Filing type: Form 8-K Amendment No. 1 (Item 5.02) filed December 22, 2025.
• Board appointments originally disclosed: reported December 17, 2025; board memberships effective January 1, 2026.
• Committee assignments: Eduardo C. Alfonso, MD → Science and Technology Committee; Steven H. Collis → Talent and Compensation Committee.
• Signatory: A. Robert D. Bailey, EVP & Chief Legal Officer.

Why It Matters Committee assignments determine which directors have direct oversight of key areas—science and technology oversight for product and R&D matters, and talent and compensation oversight for executive pay and human capital matters. For investors, these changes clarify who will influence oversight in those areas going forward; the filing contains no financial figures or executive departures beyond the previously reported board appointments.